New frontiers in translational control of the cancer genome

Cited by (388)

Items 301–388 of 388

1. TRMT6/61A-mediated tRNA m1A methylation promotes codon-dependent TAB2 translation and drives AML progression
   Zhirong Jia, Xiang Wu, Ao-Rong Ouyang, ChengZhang, Ya Liu, Guocai Wu, Zhanghui Chen, Songyu Li · 2026 · Molecular Medicine
2. RNA in cancer
   Maciej Cieśla · 2020 · Elsevier eBooks
3. The Role of RNA-Binding Proteins in Cancers
   Melika Shafeghat, Ashley E Akrami, Nima Rezaei · 2023 · Springer eBooks
4. Features and mechanisms of long-lived Myotis somatic fibroblasts in response to DNA replication stress
   Xiaoyan Huang, 中国科学院昆明动物研究所, 云南 昆明650201, 中国, Liu Xiu-Yun, Wang Wei, Liu Gao-Jing, Zhu You-Long, Wen Xiao, Li Kai-Qin, Zhao Bo, 中国科学院昆明动物研究所遗传进化与动物模型全国重点实验室, 云南 昆明 650201, 中国 et al. · 2025 · 动物学研究
5. eIF3b-driven autophagy and Wnt/β-catenin crosstalk: a novel regulatory axis in adriamycin resistance of breast cancer
   Yanhui Li, Shurao Chen, Zihui Zhao, Zhikun Yuan, Dehan Yuan · 2025 · Oncology Reviews
6. Peptides Targeting the Interaction Between Erb1 and Ytm1 Ribosome Assembly Factors
   Lidia Orea-Ordóñez, Susana Masiá, Jerónimo Bravo · 2021 · Frontiers in Molecular Biosciences
7. The role of cell cycle in reprogramming toward induced pluripotent stem cells (iPSCs)
   Irina E. Neganova · 2021 · Elsevier eBooks
8. ALG13 as a prognostic biomarker of prostate cancer associated with tumor immune infiltration and mediated by upstream ncRNA
   Maolin Xiao, Yunfeng Xiao, Wanlan Liu, Xiao Xiao, Zongke Yang · 2023 · Research Square
9. Global effects of plant virus infection, viral noncoding RNAs, and unfolded protein response on plant gene expression
   Pulkit Kanodia · 2021
10. The Truth About Tissues
    Robert E. Farrell · 2017 · Elsevier eBooks
11. Preneoplastic Lesions Fimbria Early Diagnosis Markers Underlying Timeline Mechanisms at The Origin of Ovarian Cancer in BRAC1/2 Patients: Case Reports Based on Proteogenomic Study
    Maxence Wisztorski, Philippe Saudemont, Soulaimane Aboulouard, Tristan Cardon, Fabrice Narducci, Y. Marie Robin, Anne-Sophie Lemaire, Delphine Bertin, Firas H. Kobeissy, Éric Leblanc et al. · 2021 · Research Square
12. Construction of a Prognostic Signature in Ewing’s Sarcoma: Based on RNA-binding Genes
    Bo Wu, Haoqun Xie, Wang Yibo, Zhen Guo, Hou Yuanyuan, Dong Li Zhu · 2021 · Research Square
13. Ribosome changes elicit non-canonical translation for chemosurvival in G0 leukemic cells
    C. Datta, S. Truesdell, S. Bukhari, H. Ngue, B. Buchanan, Ke Wu, O. Le Tonqueze, S. Lee, M. Granovetter, M. Boukhali et al. · 2021 · bioRxiv
14. Maternal Engineered Nanomaterial Inhalation Exposure: Cardiac Molecular Reprogramming in Progeny through Epigenetic and Epitranscriptomic Mechanisms
    Amina Kunovac · 2021
15. Oncogenic c-Myc activity increases tolerance to proteotoxic and genotoxic stress through regulation of HSF1
    Joe M. Jones, Koshiro Kiso, Cosetta Bertoli, Robertus A.M. de Bruin · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
16. Identification of four Ferroptosis Gene signatures and Establishment of a predictive model for the overall survival rate of gastric cancer
    Jiang Liu, Huakai Tian, Nantao Fu, Cegui Hu, Fei-long Zou, Zhen Zong, Zhikun Ning · 2022 · Research Square
17. Antibody–Oligonucleotide Conjugation Using a SPAAC Copper-Free Method Compatible with 10× Genomics’ Single-Cell RNA-Seq
    Dominic Paul Lee, Wang Jiehao Ray, Tan Pee Mei, Shawn S. Hoon, Jonathan Adam Scolnick, Gene Wei-Ming Yeo · 2022 · Methods in molecular biology
18. Non-Stem Bladder Cancer Cell-Derived Extracellular Vesicles Promote Cancer Stem Cell Survival in Response to Chemotherapy
    Wei-Min Chung, Ryan D. Molony, Yi‐Fen Lee · 2021 · Research Square
19. Data from TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity
    Jamilah Abusarah, Yun Cui, Nehmé El-Hachem, Abed El-Hakim El-Kadiry, Ian Hammond-Martel, Hugo Würtele, Annie Beaudry, Noël J.‐M. Raynal, Francis Robert, Jerry Pelletier et al. · 2023
20. Data from MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression
    John R. P. Knight, Constantinos Alexandrou, George Skalka, Nikola Vlahov, Kathryn A.F. Pennel, Leah Officer, Ana Teodòsio, Georgios Kanellos, David Michael Gay, Sebastian May-Wilson et al. · 2023
21. Data from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
    Shima Nakanishi, Jiannong Li, Anders Berglund, Youngchul Kim, Yonghong Zhang, Ling Zhang, Chunying Yang, Jinming Song, Raghavendra G. Mirmira, John L. Cleveland · 2023
22. Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer Types
    Mingyu Luo, Yining Liu, Min Zhao · 2023 · Biology
23. Performing Cancer Diagnosis via an Isoform Expression Ranking-based LSTM Model
    Óscar Reyes, Eduardo Pérez · 2023 · ACM Transactions on Intelligent Systems and Technology
24. Translational regulation of cell invasion through extracellular matrix—an emerging role for ribosomes
    David R. Sherwood, Isabel W. Kenny-Ganzert, Siddharthan Balachandar Thendral · 2023 · F1000Research
25. Translation of secretory mRNAs must be restrained during early oncogenesis to permit hepatocellular carcinoma initiation
    Jim C. Norman, Madeleine H. Moore, Luis Pardo, Louise E. Mitchell, Tobias Schmidt, Joseph A. Waldron, Stephanie May, Miryam Müller, Rachael C.L. Smith, Douglas Strathdee et al. · 2024 · Research Square
26. PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma
    Bhargab Kalita, Gerard Martínez-Cebrián, Justina D. McEvoy, Melody Lyn Allensworth, Michelle Knight, Alessandro Magli, Rita C. R. Perlingeiro, Michael A. Dyer, Elizabeth S. Stewart, Brian David Dynlacht · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
27. A versatile and efficient method for detecting tRNA-derived fragments
    Mei Yang, Yongzhen Mo, Daixi Ren, Hu Yan, Yiting Tian, Zhaoyang Zeng, Wei Xiong · 2024 · Molecular and Cellular Probes
28. Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathways
    Anna Herrmannová, Jan Jelı́nek, Klára Pospíšilová, Farkas Kerényi, Tomáš Vomastek, Kathleen Watt, Jan Brábek, Mahabub Pasha Mohammad, Susan Wagner, Ivan Topisirović et al. · 2024 · eLife
29. Sortase-Mediated Fluorescent Labeling of eIF4E for Investigating Translation Initiation Mechanisms
    Justin Pi, Simpson Joseph · 2025 · Biochemistry
30. EEF1AKMT4-eEF1A2 synergistically facilitates the progression of GBC by promoting ribosomal protein output
    Yuncheng Li, Qiang Gao, Yong‐chang Tang, Zhenyu Shao, Jia-ming Hu, Zengli Liu, Anda Shi, Shaohui Huang, Yunfei Xu, Zongli Zhang et al. · 2025 · Genes & Diseases
31. APOBEC3A deaminase catalyzes site-specific editing of transfer RNAs
    Karolina Hoffa-Sobiech, J. Sikora, Milosz Ruszkowski, Marta Starczak, Daniel Gackowski, Adam G. Blaszczak, Aleksandra Mierzwa, Magdalena Rakoczy, Małgorzata Marcinkowska, Ireneusz Stolarek et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
32. Integrative Proteomics and Histone PTMomics Study on Anti-TNBC Effect of JIB-04.
    Shengna Tao, Jing-Li Guo, Jingdan Zhang, Ming-Ya Zhang, Zhe Wang, Jun Zhang, Ming-Jun Li, Bin Liu, Jian Yuan, Minjia Tan et al. · 2025 · Journal of the American Society for Mass Spectrometry
33. The Role of RNA-Binding Proteins in Cancers
    Melika Shafeghat, Ashley E Akrami, Nima Rezaei · 2025 · Springer eBooks
34. m6A Immunoprecipitation from Ribosome-Bound mRNA
    Nora T. Kiledjian, Morgan J. McGrath, Crystal S. Conn · 2025 · Methods in enzymology on CD-ROM/Methods in enzymology
35. Additional file 17 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Yuxin Wen, Yongyi Huang, Kai Gao, Yang, Wenhan, Bai, Feng, Ling, Lijuan et al. · 2022 · Figshare
36. Additional file 9 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Bai, Feng, Ling, Lijuan et al. · 2022 · Figshare
37. Additional file 10 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
38. Additional file 11 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
39. Additional file 16 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
40. Additional file 7 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
41. Additional file 1 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
42. Additional file 4 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
43. Additional file 13 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
44. Additional file 6 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
45. Additional file 8 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
46. Additional file 5 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
47. Additional file 18 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Bai, Feng, Ling, Lijuan et al. · 2022 · Figshare
48. Additional file 15 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
49. Additional file 2 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
50. Additional file 1 of Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
    Forum B Kayastha, Noah B. Herrington, Bandish B. Kapadia, Anirban Roychowdhury, Nahid M. Nanaji, Kellogg, Glen E., Ronald B. Gartenhaus · 2022 · Figshare
51. Additional file 14 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
52. Additional file 12 of PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming
    Chen, Qianqian, Wang, Yiling, Yang, Lin, Sun, Liyuan, Wen, Yuxin, Yongyi Huang, Kai Gao, Yang, Wenhan, Feng Bai, Ling, Lijuan et al. · 2022 · Figshare
53. Integrated spatial and single-cell transcriptomics reveals RPL8 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
    Jinna Michelle Tan, Junzhu Liang, Yaoyang Li, Jiaqian He, Hui Yin, Hemeng Wu, Yuzhen Luo, Mingfen Li, Fuli Long, Hongsheng Lin · 2026 · Translational Oncology
54. RNA‐Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications
    Linlin Chang, Bin Lu, Haotian Shang, Wenqin Ding, Chunhua Wei, Xiaotian Qi, Pengxing He · 2026 · MedComm – Oncology
55. Depletion of rRNA Methyltranferase METTL5 Enhances Anti-Tumor Immune Response via Neoantigen Generated from Cryptic Translation
    Yangyi Zhang, Xiaoyan Shi, Yuci Wang, Ruiqi Wang, Folan Lin, Yanlan Cao, Wanqiu Li, Hao Chen · 2026 · eLife
56. Conséquences traductionnelles de la perte de 4E-BP1 dans l'adénocarcinome pancréatique
    David Müller · 2016
57. Implication de la protéine de biogenèse des ribosomes Rsl24d1 dans l'homéostasie de cellules souches embryonnaires murines
    Marion Bruelle · 2018
58. Etude de l’implication du complexe eIF4F dans la réponse immune antitumorale via la régulation traductionnelle de l’axe STAT1-PD-L1 dans le mélanome métastatique
    Ramdane Guemiri · 2018
59. Rôle des protéines de liaison à l'ARN hnRNP H et hnRNP F dans les régulations traductionnelles dans les glioblastomes
    Morgane Le Bras · 2018
60. Stress du réticulum endoplasmique dans les leucémies aiguës myéloïdes : rôle et régulation du facteur de transcription XBP1
    Céline Philippe · 2018 · theses.fr (ABES)
61. Protéostase cellulaire et tumeurs solides
    Chloé Sauzay · 2018
62. Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
    Charlène Estrada · 2020 · theses.fr (ABES)
63. Ribosome biogenesis as a novel therapeutic target in breast cancer
    Piero Lo Monaco · 2020
64. Altérations de composition des ribosomes dans les cancers du sein : analyses de cohortes humaines et modèles cellulaires
    Flora Nguyen Van Long · 2019
65. Recherche de biomarqueurs pronostiques dans le mélanome muqueux non opérable et/ou métastatique : Régulation traductionnelle de SOX10 par l’hexokinase 2 et modulation de l'agressivité tumorale dans le mélanome cutané
    Antoine Moya‐Plana · 2020 · theses.fr (ABES)
66. Identification et caractérisation de gènes candidats pour la découverte de nouveaux mécanismes physiopathologiques à l'origine de l'anémie de Blackfan-Diamond
    Aurore Anton · 2020
67. Translational control in ovarian cancer : role of the glutaminyl-tRNA synthetase QARS in DNA damage response
    Martina Serafini · 2024 · theses.fr (ABES)
68. Unbiased profiling of translational landscape reveals TNFR2 as a translation-dependent vulnerability in colorectal cancer
    Yiying Chen, Yufeng Gao, Hai-Xia Wang, Wei-Qiang Li, Fan-Qi Zhou, Hao Sun, Jia Yu, Dongling Zou, Fang Wang · 2026 · Journal of experimental & clinical cancer research : CR
69. Pan-cancer analysis of DDX31 as a promising predictor for clinical prognosis and immunotherapy response
    Qianwen Rao, Jiajia Dong, Zhuoran Qi, Mengzhou Guo, Yuemei Yan, Xin Cao · 2026 · The Innovation Medicine
70. PIWIL1 activates the R2TP-TELO2-mTORC1 axis independently of piRNA to promote TOP mRNA translation in gastric cancer
    Tianqu Fan, Jiangsha Zhao, Li L, Meihua Cui, Jiawei Zhang, Tian H. Chi, Shuo Shi · 2026 · Oncogene
71. Copy Number Alterations Suggest a Functional Switch from Innate Immunity to DNA Repair and Drive Clinical Heterogeneity in Plasma Cell Dyscrasias
    Igor Valentim Barreto, Wallax Augusto Silva Ferreira, Guilherme Passos de Morais, Jéssica Sousa Cavalcante, Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Leidivan Sousa da Cunha, Anna Karolyna da Costa Machado, Isabelle Magalhães Farias, Beatriz Maria Dias Nogueira et al. · 2026 · International Journal of Translational Medicine
72. CPEB4 deficiency promotes vasculogenic mimicry and resistance to anti-angiogenic therapy in hepatocellular carcinoma
    Beatriz Cárdenas, Salvador Naranjo Suárez, Isabel Baroja, Ana Mendez, Pau Bosch-i-Crespo, Carmen Gallardo-Martínez, Marta Ramírez-Pedraza, Maria Eugenia Delgado, Laura Morató, Eulàlia Belloc et al. · 2026 · Gut
73. The translation landscape of ovarian clear cell carcinoma indicates that RBM4 plays a pro-oncogenic role in tumor progression
    Yiying Chen, Dongxu Lu, Yaqi Xing, Jing He, Sumei Zhang, Xiaoxi Wang, Mei Li, Yuming Wang, Yike Gao, Anqi Wang et al. · 2026 · Oncogene
74. Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier
    Davide Ruggero · 2026 · Journal of Clinical Investigation
75. Cross‐Strand Chimeric RNA Signature Predicts Prognosis and Identifies Tumor Immune Microenvironment Associations in Gastric Cancer
    Shuqiang Cheng, Miaomiao Cui, Xuehui Li, Y L Huang, Xianhui Wen, Sixi Wei, Shaocun Zhang, Hai Jun Huang · 2026 · Human Mutation
76. Enhanced IGFL1 translation in response to IL-1β is controlled by distinct 3’UTR elements
    Giulia Cardamone, Melanie Flohr, Rebecca Raue, Irina I. Bode, Sofie Patrizia Meyer, Sven Hauns, Rolf Backofen, Tobias Schmid · 2026 · PLoS ONE
77. Post-transcriptional regulation in cancer chemoresistance
    Sabrina De Lella, Franca Esposito, Danilo Swann Matassa, Rosario Avolio · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
78. Integrating Single-Cell, Bulk, and Spatial Transcriptomics Unveils a Novel Ribosome Biogenesis-Related Prognostic Model and Defines RPS19BP1 as a Pro-Oncogenic Regulator in Lung Adenocarcinoma
    Shan Chen, Pengfei Du, Qiang Luo, Shuang You, Dingkun Huang, Qian Ou, Mingyi Zhang, Leichong Chen, Dejun Zhang, Rui Meng · 2026 · International Journal of Molecular Sciences
79. Translational Control as a Driver of Tumor Plasticity, Metastasis, and Therapeutic Resistance in Triple-Negative Breast Cancer
    Tiffany J. Rios-Fuller, Harold I. Saavedra, Robert J. Schneider · 2026 · Disease and Therapeutics
80. Ribosome biogenesis and selective translational control as oncogenic vulnerabilities in hematologic malignancies
    Juan Luiz Coelho‐Silva, João Agostinho Machado‐Neto · 2026 · Molecular Cancer
81. A Dimeric Protein-RNA Glue Promotes Multivalent eIF4A-RNA Assembly
    Jie Liu, Megan K. Moore, Kevin Lou, Douglas R. Wassarman, A. Arab, Samuel Ojeda, Barbara Karakyriakou, Ann-Sophie Koglin, Christopher J. Ott, L. Gilbert et al. · 2026 · ACS Central Science
82. Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer
    Martina Serafini, Francesca Di Fazio, Yann Kieffer, Lounes Djerroudi, Léonie Dec, Michael Richard, Yann Aubert, Franco Marchesoni-Acland, Manuel D. Díaz‐Muñoz, Anne Vincent‐Salomon et al. · 2026 · Nature Communications
83. Fluorescence-Based mRNA Translation Reporter
    Jemima Riess, Gunhild Sommer, Tilman Heise · 2026 · Methods in molecular biology
84. When RNA wears a sugar coat: Emerging biology and cancer relevance of GlycoRNA
    Ting-Ju Ren, Zhuoqun Lin, 谢文瑞, Ruizi Peng, Lingfang Wang · 2026 · Cancer Letters
85. METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis.
    Lauren Buie, Simone Hausmann, Juhyung Park, Sabeen Ikram, Tourkian Chasan, Xiao-Jie Yang, Natasha M. Flores, Pawel K. Mazur, O. Gozani · 2026 · Journal of Biological Chemistry
86. BindingDB Entry 50010656: Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.
    BindingDB · 2021 · UC San Diego
87. BindingDB Entry 50018392: Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.
    BindingDB · 2024 · UC San Diego
88. BindingDB Entry 50000895: Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.
    BindingDB · 2020 · UC San Diego